0001415889-24-018603.txt : 20240701
0001415889-24-018603.hdr.sgml : 20240701
20240701164059
ACCESSION NUMBER: 0001415889-24-018603
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240701
FILED AS OF DATE: 20240701
DATE AS OF CHANGE: 20240701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AKKARAJU SRINIVAS
CENTRAL INDEX KEY: 0001253170
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-42143
FILM NUMBER: 241091261
MAIL ADDRESS:
STREET 1: 565 EVERETT AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALUMIS INC.
CENTRAL INDEX KEY: 0001847367
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 280 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-231-6625
MAIL ADDRESS:
STREET 1: 280 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: ESKER THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20230427
FORMER COMPANY:
FORMER CONFORMED NAME: FL2021-001, Inc.
DATE OF NAME CHANGE: 20210222
4
1
form4-07012024_080756.xml
X0508
4
2024-07-01
0001847367
ALUMIS INC.
ALMS
0001253170
AKKARAJU SRINIVAS
C/O ALUMIS INC.
280 EAST GRAND AVENUE
SOUTH SAN FRANCISCO
CA
94080
true
false
false
false
0
Class A Common Stock
2024-07-01
4
C
0
1703998
A
1703998
I
By Samsara BioCapital, L.P.
Class A Common Stock
2024-07-01
4
D
0
1703998
D
0
I
By Samsara BioCapital, L.P.
Common Stock
2024-07-01
4
A
0
1703998
A
1703998
I
By Samsara BioCapital, L.P.
Series C Preferred Stock
2024-07-01
4
C
0
1703998
0
D
Class A Common Stock
1703998
0
I
By Samsara BioCapital, L.P.
Upon closing of the Issuer's initial public offering, each share of Series C Preferred Stock (the "Preferred Stock") automatically converted on a 4.675-to-one basis into shares of Class A Common Stock. The Preferred Stock had no expiration date.
Shares are held directly by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara GP") is the general partner of Samsara LP. The Reporting Person, as the managing member of Samsara GP, shares voting and investment authority over the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein.
Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of voting Common Stock.
/s/ Sara Klein, Attorney-in-Fact
2024-07-01